Business Wire

GIGABYTE

29.5.2023 11:03:27 CEST | Business Wire | Press release

Share
GIGABYTE’s AI Servers with Superchips Shine at COMPUTEX, Redefining a New Era of Computing

GIGABYTE is exhibiting cutting-edge technologies and solutions at COMPUTEX 2023, presenting the theme “Future of COMPUTING”. From May 30th to June 2nd, GIGABYTE is showcasing over 110 products that are driving future industry transformation, demonstrating the emerging trends of AI technology and sustainability, on the 1st floor, Taipei Nangang Exhibition Center, Hall 1.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005657/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

Win Big with AI through GIGABYTE’s Pioneering GPU/HPC Servers

GIGABYTE and its subsidiary, Giga Computing, are introducing unparalleled AI/HPC server lineups, leading the era of exascale supercomputing. One of the stars is the industry’s first NVIDIA-certified HGX H100 8-GPU SXM5 server, G593-SD0. Equipped with the 4th Gen Intel Xeon Scalable Processors and GIGABYTE’s industry-leading thermal design, G593-SD0 can perform extremely intensive workloads from generative AI and deep learning model training within a density-optimized 5U server chassis, making it a top choice for data centers aimed for AI breakthroughs.

In addition, GIGABYTE is debuting AI computing servers supporting NVIDIA Grace CPU and Grace Hopper Superchips. The high-density servers are accelerated with NVLink-C2C technology under the ARM Neoverse V2 platform, setting a new standard for AI/HPC computing efficiency and bandwidth.

Embrace Sustainability with GIGABYTE’s World-Acclaimed Green Computing Solutions

GIGABYTE’s green computing solutions are elevating the standards of data center energy efficiency to the next level. It is the first time for GIGABYTE to showcase three models of immersion cooling tanks at COMPUTEX, to demonstrate how green computing can eliminate the need for power-hungry fans and air conditioning. The solutions enable customers to therefore meet their sustainability goals while dealing with the surging demand for computing-heavy innovations.

In addition to green computing solutions, GIGABYTE is also highlighting its long-standing efforts in achieving “sustainable productivity” at COMPUTEX for the first time. GIGABYTE has been developing innovative eco-friendly products, optimizing production lines, which have reduced energy consumption by 34% and emissions by 43% since 2009, and practicing circular economy through e-waste repair, recycling, and refurbishment. In 2021 and 2022, GIGABYTE was rated “Leadership-Level” by CDP Climate Assessment for its distinguished sustainability actions and accomplishments.

Advance Data Centers with Next-Generation Server Selections

Technology development and digital services rely heavily on advanced data centers. GIGABYTE is exhibiting a wide range of servers and motherboards suitable for cloud computing, data storage, and edge computing, as well as servers displayed in EIA and OCP (Open Compute Project) standardized racks. The latest GIGABYTE enterprise products support the latest chips from AMD, Ampere, Intel, and NVIDIA, which allow data centers to benefit from optimized performance, flexibility, scalability, and efficiency.

Enable Smart Industry with GIGABYTE’s Superior AI-Driven Deployment

The development of network communication has spurred the rise of the Internet of Things (IoT). At COMPUTEX, GIGABYTE is showcasing how IoT can utilize AI technology to modernize manufacturing, retail, autonomous vehicles, healthcare, and other sectors. The key technology on display includes industrial motherboards, embedded systems, microcomputers, AI image recognition systems, and the Internet of Vehicles, leveraging next-generation chip technology to unlock boundless opportunities through digital transformation.

Reshape the Game with Award-Winning AORUS and AERO Computers

GIGABYTE has always adhered to a design philosophy that delivers outstanding consumer experience. AORUS gaming and AERO creator series have won 15 Red Dot Design Awards in 2023 across motherboards, graphics cards, laptops, large 4K monitors, and gaming peripherals, demonstrating GIGABYTE’s dedicated innovation and aesthetic excellence. In addition to the award-winning AORUS and AERO products, GIGABYTE will also showcase various selections of motherboards, SSD drives, and DIY kits, impressing tech enthusiasts with abundant choices of excellence.

Visit GIGABYTE’s COMPUTEX event page.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230525005657/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Investor Supporting Japan’s Entertainment Industry, Yoshihiro Shimamura, to Visit France Workshop to be Held During the Cannes Film Festival28.4.2026 04:00:00 CEST | Press release

Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of Hankyu Hanshin Holdings, Inc.—a major Japanese entertainment conglomerate known for producing content enjoyed across generations—and became a major shareholder (as of March 25, 2026). Through such investments, the company aims to support the global expansion of Japanese entertainment while exploring synergies with its own interna

Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release

Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye